|
Fentanyl - Hameln 50mcg/ml
Fentanyl
- Strength / route
- 50mcg/ml · Injection
- Qty
- 3,000 Ampoule
- Total
- 85,365,000
- Group
- N1
- Manufacturer
- Siegfried Hameln GmbH (Germany)
- Province / Facility
- Ca Mau · 96145
|
VN-17326-13 |
50mcg/ml
Injection
|
Ampoule |
3,000
|
28,455
|
85,365,000
|
N1 |
Siegfried Hameln GmbH
Germany
|
Ca Mau
96145
|
2026-03-27 |
|
Flodicar 5 mg MR
Felodipin
- Strength / route
- 5mg · Oral
- Qty
- 4,000 Tablet
- Total
- 4,788,000
- Group
- N3
- Manufacturer
- Pymepharco JSC (Vietnam)
- Province / Facility
- Phu Yen · 54018
|
893110693224 |
5mg
Oral
|
Tablet |
4,000
|
1,197
|
4,788,000
|
N3 |
Pymepharco JSC
Vietnam
|
Phu Yen
54018
|
2026-03-27 |
|
Flumetholon 0,1
Fluorometholon
- Strength / route
- 5mg/5ml · Ophthalmic
- Qty
- 300 Vial
- Total
- 9,651,600
- Group
- N1
- Manufacturer
- Santen Pharmaceutical Co., Ltd. – Shiga Plant (Japan)
- Province / Facility
- Hanoi · 01055
|
VN-18452-14 |
5mg/5ml
Ophthalmic
|
Vial |
300
|
32,172
|
9,651,600
|
N1 |
Santen Pharmaceutical Co., Ltd. – Shiga Plant
Japan
|
Hanoi
01055
|
2026-03-27 |
|
ForminHasan XR 500
Metformin hydroclorid
- Strength / route
- 500mg · Oral
- Qty
- 20,000 Tablet
- Total
- 12,880,000
- Group
- N4
- Manufacturer
- Hasan-Dermapharm Joint Venture Co., Ltd. (Vietnam)
- Province / Facility
- Phu Yen · 54018
|
893110296924 |
500mg
Oral
|
Tablet |
20,000
|
644
|
12,880,000
|
N4 |
Hasan-Dermapharm Joint Venture Co., Ltd.
Vietnam
|
Phu Yen
54018
|
2026-03-27 |
|
Forxiga
Dapagliflozin (as Dapagliflozin propanediol monohydrate)
- Strength / route
- 10mg · Oral
- Qty
- 143,000 Tablet
- Total
- 2,717,000,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd (Manufacturing site: United States, Packaging and batch release site: United Kingdom)
- Province / Facility
- Hai Duong · 30013
|
VN3-37-18 |
10mg
Oral
|
Tablet |
143,000
|
19,000
|
2,717,000,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd
Manufacturing site: United States, Packaging and batch release site: United Kingdom
|
Hai Duong
30013
|
2026-03-27 |
|
Forxiga
Dapagliflozin
- Strength / route
- 10mg · Oral
- Qty
- 10,000 Tablet
- Total
- 190,000,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd (United States)
- Province / Facility
- Hai Duong · 30016
|
VN3-37-18 |
10mg
Oral
|
Tablet |
10,000
|
19,000
|
190,000,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd
United States
|
Hai Duong
30016
|
2026-03-27 |
|
Forxiga
Dapagliflozin
- Strength / route
- 10mg · Oral
- Qty
- 30,000 Tablet
- Total
- 570,000,000
- Group
- N1
- Manufacturer
- AstraZeneca Pharmaceuticals LP (Packaging, batch release: AstraZeneca UK Limited- UK) (USA)
- Province / Facility
- Thai Nguyen · 19013
|
VN3-37-18 |
10mg
Oral
|
Tablet |
30,000
|
19,000
|
570,000,000
|
N1 |
AstraZeneca Pharmaceuticals LP (Packaging, batch release: AstraZeneca UK Limited- UK)
USA
|
Thai Nguyen
19013
|
2026-03-27 |
|
Forxiga
Dapagliflozin
- Strength / route
- 5mg · Oral
- Qty
- 5,000 Tablet
- Total
- 95,000,000
- Group
- N1
- Manufacturer
- AstraZeneca Pharmaceuticals LP (Packaging, batch release: AstraZeneca UK Limited- UK) (USA)
- Province / Facility
- Thai Nguyen · 19013
|
VN3-38-18 |
5mg
Oral
|
Tablet |
5,000
|
19,000
|
95,000,000
|
N1 |
AstraZeneca Pharmaceuticals LP (Packaging, batch release: AstraZeneca UK Limited- UK)
USA
|
Thai Nguyen
19013
|
2026-03-27 |
|
Forxiga
Dapagliflozin
- Strength / route
- 10mg · Oral
- Qty
- 28,000 Tablet
- Total
- 532,000,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd (Manufacturing site: United States, Packaging and batch release site: United Kingdom)
- Province / Facility
- Hanoi · 01055
|
VN3-37-18 |
10mg
Oral
|
Tablet |
28,000
|
19,000
|
532,000,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd
Manufacturing site: United States, Packaging and batch release site: United Kingdom
|
Hanoi
01055
|
2026-03-27 |
|
Fresofol 1% MCT/LCT
Propofol
- Strength / route
- 1% (10mg/ml); 20ml · Injection
- Qty
- 30 Ampoule
- Total
- 2,640,000
- Group
- N1
- Manufacturer
- Fresenius Kabi Austria GmbH. (Austria)
- Province / Facility
- Lam Dong · 68790
|
VN-17438-13 |
1% (10mg/ml); 20ml
Injection
|
Ampoule |
30
|
88,000
|
2,640,000
|
N1 |
Fresenius Kabi Austria GmbH.
Austria
|
Lam Dong
68790
|
2026-03-27 |
|
Fresofol 1% MCT/LCT
Propofol
- Strength / route
- 1% (10mg/ml); 20ml · Injection
- Qty
- 30 Ampoule
- Total
- 2,640,000
- Group
- N1
- Manufacturer
- Fresenius Kabi Austria GmbH. (Austria)
- Province / Facility
- Lam Dong · 68930
|
VN-17438-13 |
1% (10mg/ml); 20ml
Injection
|
Ampoule |
30
|
88,000
|
2,640,000
|
N1 |
Fresenius Kabi Austria GmbH.
Austria
|
Lam Dong
68930
|
2026-03-27 |
|
Fresofol 1% MCT/LCT
Propofol
- Strength / route
- 1% (10mg/ml); 20ml · Injection
- Qty
- 10 Ampoule
- Total
- 880,000
- Group
- N1
- Manufacturer
- Fresenius Kabi Austria GmbH. (Austria)
- Province / Facility
- Lam Dong · 68860
|
VN-17438-13 |
1% (10mg/ml); 20ml
Injection
|
Ampoule |
10
|
88,000
|
880,000
|
N1 |
Fresenius Kabi Austria GmbH.
Austria
|
Lam Dong
68860
|
2026-03-27 |
|
Fretamuc
Acetylcystein
- Strength / route
- 200mg · Oral
- Qty
- 27,000 Tablet
- Total
- 18,306,000
- Group
- N2
- Manufacturer
- Fremed Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01107
|
893100153023 |
200mg
Oral
|
Tablet |
27,000
|
678
|
18,306,000
|
N2 |
Fremed Pharmaceutical JSC
Vietnam
|
Hanoi
01107
|
2026-03-27 |
|
Fretamuc
Acetylcystein
- Strength / route
- 200mg · Oral
- Qty
- 27,000 Tablet
- Total
- 18,306,000
- Group
- N2
- Manufacturer
- Fremed Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01OR2
|
893100153023 |
200mg
Oral
|
Tablet |
27,000
|
678
|
18,306,000
|
N2 |
Fremed Pharmaceutical JSC
Vietnam
|
Hanoi
01OR2
|
2026-03-27 |
|
Fretamuc
Acetylcystein
- Strength / route
- 200mg · Oral
- Qty
- 27,000 Tablet
- Total
- 18,306,000
- Group
- N2
- Manufacturer
- Fremed Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01E53
|
893100153023 |
200mg
Oral
|
Tablet |
27,000
|
678
|
18,306,000
|
N2 |
Fremed Pharmaceutical JSC
Vietnam
|
Hanoi
01E53
|
2026-03-27 |
|
Fretamuc
Acetylcystein
- Strength / route
- 200mg · Oral
- Qty
- 27,000 Tablet
- Total
- 18,306,000
- Group
- N2
- Manufacturer
- Fremed Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01E64
|
893100153023 |
200mg
Oral
|
Tablet |
27,000
|
678
|
18,306,000
|
N2 |
Fremed Pharmaceutical JSC
Vietnam
|
Hanoi
01E64
|
2026-03-27 |
|
Fretamuc
Acetylcystein
- Strength / route
- 200mg · Oral
- Qty
- 27,000 Tablet
- Total
- 18,306,000
- Group
- N2
- Manufacturer
- Fremed Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01E58
|
893100153023 |
200mg
Oral
|
Tablet |
27,000
|
678
|
18,306,000
|
N2 |
Fremed Pharmaceutical JSC
Vietnam
|
Hanoi
01E58
|
2026-03-27 |
|
Fucidin
Fusidic acid
- Strength / route
- 2% (w/w) · Topical
- Qty
- 500 Tube
- Total
- 37,537,500
- Group
- N1
- Manufacturer
- Leo Laboratories Limited (Ireland)
- Province / Facility
- Hanoi · 01055
|
VN-14209-11 |
2% (w/w)
Topical
|
Tube |
500
|
75,075
|
37,537,500
|
N1 |
Leo Laboratories Limited
Ireland
|
Hanoi
01055
|
2026-03-27 |
|
GLARITUS
Insulin Glargine 100IU/1ml
- Strength / route
- 300UI/ 3ml; 3ml · Injection
- Qty
- 500 Pen injector
- Total
- 110,000,000
- Group
- N5
- Manufacturer
- Wockhardt Limited (India)
- Province / Facility
- Quang Ngai · 51225
|
890410091623 |
300UI/ 3ml; 3ml
Injection
|
Pen injector |
500
|
220,000
|
110,000,000
|
N5 |
Wockhardt Limited
India
|
Quang Ngai
51225
|
2026-03-27 |
|
GLARITUS
Insulin Glargine 100IU/1ml
- Strength / route
- 300UI/ 3ml; 3ml · Injection
- Qty
- 3,150 Pen injector
- Total
- 693,000,000
- Group
- N5
- Manufacturer
- Wockhardt Limited (India)
- Province / Facility
- Quang Ngai · 51002
|
890410091623 |
300UI/ 3ml; 3ml
Injection
|
Pen injector |
3,150
|
220,000
|
693,000,000
|
N5 |
Wockhardt Limited
India
|
Quang Ngai
51002
|
2026-03-27 |
|
Galvus Met 50mg/1000mg
Vildagliptin + metformin
- Strength / route
- 50mg + 1000mg · Oral
- Qty
- 10,000 Tablet
- Total
- 92,740,000
- Group
- N1
- Manufacturer
- Novartis Pharma Produktions GmbH (Packaging, batch release: Lek d.d., PE Proizvodnja Lendava, Slovenia) (Germany)
- Province / Facility
- Thai Nguyen · 19013
|
400110771824 |
50mg + 1000mg
Oral
|
Tablet |
10,000
|
9,274
|
92,740,000
|
N1 |
Novartis Pharma Produktions GmbH (Packaging, batch release: Lek d.d., PE Proizvodnja Lendava, Slovenia)
Germany
|
Thai Nguyen
19013
|
2026-03-27 |
|
Ganfort
Bimatoprost + timolol
- Strength / route
- 0.3mg/ml + 5mg/ml · Ophthalmic
- Qty
- 350 Vial
- Total
- 89,596,500
- Group
- N1
- Manufacturer
- Allergan Pharmaceuticals Ireland (Ireland)
- Province / Facility
- Quang Nam · 49004
|
539110019923 |
0.3mg/ml + 5mg/ml
Ophthalmic
|
Vial |
350
|
255,990
|
89,596,500
|
N1 |
Allergan Pharmaceuticals Ireland
Ireland
|
Quang Nam
49004
|
2026-03-27 |
|
Gelactive Fort
magnesium hydroxyd + nhom hydroxyd + simethicon
- Strength / route
- 400mg + 300mg + 30mg · Oral
- Qty
- 80,600 Sachet
- Total
- 233,740,000
- Group
- N4
- Manufacturer
- Hasan-Dermapharm J.V. Co., Ltd. (Vietnam)
- Province / Facility
- Hanoi · 01107
|
893100473424 |
400mg + 300mg + 30mg
Oral
|
Sachet |
80,600
|
2,900
|
233,740,000
|
N4 |
Hasan-Dermapharm J.V. Co., Ltd.
Vietnam
|
Hanoi
01107
|
2026-03-27 |
|
Gelactive Fort
magnesium hydroxyd + nhom hydroxyd + simethicon
- Strength / route
- 400mg + 300mg + 30mg · Oral
- Qty
- 80,600 Sachet
- Total
- 233,740,000
- Group
- N4
- Manufacturer
- Hasan-Dermapharm J.V. Co., Ltd. (Vietnam)
- Province / Facility
- Hanoi · 01OR2
|
893100473424 |
400mg + 300mg + 30mg
Oral
|
Sachet |
80,600
|
2,900
|
233,740,000
|
N4 |
Hasan-Dermapharm J.V. Co., Ltd.
Vietnam
|
Hanoi
01OR2
|
2026-03-27 |
|
Gelactive Fort
magnesium hydroxyd + nhom hydroxyd + simethicon
- Strength / route
- 400mg + 300mg + 30mg · Oral
- Qty
- 80,600 Sachet
- Total
- 233,740,000
- Group
- N4
- Manufacturer
- Hasan-Dermapharm J.V. Co., Ltd. (Vietnam)
- Province / Facility
- Hanoi · 01E53
|
893100473424 |
400mg + 300mg + 30mg
Oral
|
Sachet |
80,600
|
2,900
|
233,740,000
|
N4 |
Hasan-Dermapharm J.V. Co., Ltd.
Vietnam
|
Hanoi
01E53
|
2026-03-27 |
|
Gelactive Fort
magnesium hydroxyd + nhom hydroxyd + simethicon
- Strength / route
- 400mg + 300mg + 30mg · Oral
- Qty
- 80,600 Sachet
- Total
- 233,740,000
- Group
- N4
- Manufacturer
- Hasan-Dermapharm J.V. Co., Ltd. (Vietnam)
- Province / Facility
- Hanoi · 01E64
|
893100473424 |
400mg + 300mg + 30mg
Oral
|
Sachet |
80,600
|
2,900
|
233,740,000
|
N4 |
Hasan-Dermapharm J.V. Co., Ltd.
Vietnam
|
Hanoi
01E64
|
2026-03-27 |
|
Gelactive Fort
magnesium hydroxyd + nhom hydroxyd + simethicon
- Strength / route
- 400mg + 300mg + 30mg · Oral
- Qty
- 80,600 Sachet
- Total
- 233,740,000
- Group
- N4
- Manufacturer
- Hasan-Dermapharm J.V. Co., Ltd. (Vietnam)
- Province / Facility
- Hanoi · 01E58
|
893100473424 |
400mg + 300mg + 30mg
Oral
|
Sachet |
80,600
|
2,900
|
233,740,000
|
N4 |
Hasan-Dermapharm J.V. Co., Ltd.
Vietnam
|
Hanoi
01E58
|
2026-03-27 |
|
Gemita 200mg
Gemcitabin
- Strength / route
- 200mg · Infusion
- Qty
- 4,100 Vial
- Total
- 471,500,000
- Group
- N2
- Manufacturer
- Fresenius Kabi Oncology Limited (India)
- Province / Facility
- Ho Chi Minh City · 79431
|
VN-21730-19 |
200mg
Infusion
|
Vial |
4,100
|
115,000
|
471,500,000
|
N2 |
Fresenius Kabi Oncology Limited
India
|
Ho Chi Minh City
79431
|
2026-03-27 |
|
Gliatilin
Choline alfoscerat
- Strength / route
- 1000mg/4ml · Injection
- Qty
- 4,100 Ampoule
- Total
- 284,130,000
- Group
- N1
- Manufacturer
- Italfarmaco S.P.A (Italy)
- Province / Facility
- Ho Chi Minh City · 79431
|
VN-13244-11 |
1000mg/4ml
Injection
|
Ampoule |
4,100
|
69,300
|
284,130,000
|
N1 |
Italfarmaco S.P.A
Italy
|
Ho Chi Minh City
79431
|
2026-03-27 |
|
Glizym-M
Gliclazid + metformin
- Strength / route
- 80mg + 500mg · Oral
- Qty
- 100,000 Tablet
- Total
- 320,000,000
- Group
- N5
- Manufacturer
- M/s Panacea Biotec Pharma Ltd. (India)
- Province / Facility
- Hanoi · 01107
|
VN3-343-21 |
80mg + 500mg
Oral
|
Tablet |
100,000
|
3,200
|
320,000,000
|
N5 |
M/s Panacea Biotec Pharma Ltd.
India
|
Hanoi
01107
|
2026-03-27 |
|
Glizym-M
Gliclazid + metformin
- Strength / route
- 80mg + 500mg · Oral
- Qty
- 100,000 Tablet
- Total
- 320,000,000
- Group
- N5
- Manufacturer
- M/s Panacea Biotec Pharma Ltd. (India)
- Province / Facility
- Hanoi · 01OR2
|
VN3-343-21 |
80mg + 500mg
Oral
|
Tablet |
100,000
|
3,200
|
320,000,000
|
N5 |
M/s Panacea Biotec Pharma Ltd.
India
|
Hanoi
01OR2
|
2026-03-27 |
|
Glizym-M
Gliclazid + metformin
- Strength / route
- 80mg + 500mg · Oral
- Qty
- 100,000 Tablet
- Total
- 320,000,000
- Group
- N5
- Manufacturer
- M/s Panacea Biotec Pharma Ltd. (India)
- Province / Facility
- Hanoi · 01E53
|
VN3-343-21 |
80mg + 500mg
Oral
|
Tablet |
100,000
|
3,200
|
320,000,000
|
N5 |
M/s Panacea Biotec Pharma Ltd.
India
|
Hanoi
01E53
|
2026-03-27 |
|
Glizym-M
Gliclazid + metformin
- Strength / route
- 80mg + 500mg · Oral
- Qty
- 100,000 Tablet
- Total
- 320,000,000
- Group
- N5
- Manufacturer
- M/s Panacea Biotec Pharma Ltd. (India)
- Province / Facility
- Hanoi · 01E64
|
VN3-343-21 |
80mg + 500mg
Oral
|
Tablet |
100,000
|
3,200
|
320,000,000
|
N5 |
M/s Panacea Biotec Pharma Ltd.
India
|
Hanoi
01E64
|
2026-03-27 |
|
Glizym-M
Gliclazid + metformin
- Strength / route
- 80mg + 500mg · Oral
- Qty
- 100,000 Tablet
- Total
- 320,000,000
- Group
- N5
- Manufacturer
- M/s Panacea Biotec Pharma Ltd. (India)
- Province / Facility
- Hanoi · 01E58
|
VN3-343-21 |
80mg + 500mg
Oral
|
Tablet |
100,000
|
3,200
|
320,000,000
|
N5 |
M/s Panacea Biotec Pharma Ltd.
India
|
Hanoi
01E58
|
2026-03-27 |
|
Glucophage 500mg
Metformin
- Strength / route
- 500mg · Oral
- Qty
- 53,000 Tablet
- Total
- 84,694,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Hanoi · 01055
|
VN-21993-19 |
500mg
Oral
|
Tablet |
53,000
|
1,598
|
84,694,000
|
N1 |
Merck Sante s.a.s
France
|
Hanoi
01055
|
2026-03-27 |
|
Glucophage 500mg
Metformin
- Strength / route
- 500mg · Oral
- Qty
- 53,000 Tablet
- Total
- 84,694,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Hanoi · 01055
|
300110016124 |
500mg
Oral
|
Tablet |
53,000
|
1,598
|
84,694,000
|
N1 |
Merck Sante s.a.s
France
|
Hanoi
01055
|
2026-03-27 |
|
Glucophage 850mg
Metformin
- Strength / route
- 850mg · Oral
- Qty
- 11,000 Tablet
- Total
- 37,862,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Hanoi · 01055
|
VN-21908-19 |
850mg
Oral
|
Tablet |
11,000
|
3,442
|
37,862,000
|
N1 |
Merck Sante s.a.s
France
|
Hanoi
01055
|
2026-03-27 |
|
Glucophage 850mg
Metformin
- Strength / route
- 850mg · Oral
- Qty
- 11,000 Tablet
- Total
- 37,862,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Hanoi · 01055
|
300110016224 |
850mg
Oral
|
Tablet |
11,000
|
3,442
|
37,862,000
|
N1 |
Merck Sante s.a.s
France
|
Hanoi
01055
|
2026-03-27 |
|
Glucophage XR 1000mg
Metformin
- Strength / route
- 1000mg · Oral
- Qty
- 10,000 Tablet
- Total
- 48,430,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Hanoi · 01055
|
300110016324 |
1000mg
Oral
|
Tablet |
10,000
|
4,843
|
48,430,000
|
N1 |
Merck Sante s.a.s
France
|
Hanoi
01055
|
2026-03-27 |
|
Glucophage XR 750mg
Metformin hydrochlorid
- Strength / route
- 750mg · Oral
- Qty
- 10,000 Tablet
- Total
- 36,770,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Hai Duong · 30013
|
300110016424 |
750mg
Oral
|
Tablet |
10,000
|
3,677
|
36,770,000
|
N1 |
Merck Sante s.a.s
France
|
Hai Duong
30013
|
2026-03-27 |
|
Glucophage XR 750mg
Metformin
- Strength / route
- 750mg · Oral
- Qty
- 120,000 Tablet
- Total
- 441,240,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Hanoi · 01055
|
300110016424 |
750mg
Oral
|
Tablet |
120,000
|
3,677
|
441,240,000
|
N1 |
Merck Sante s.a.s
France
|
Hanoi
01055
|
2026-03-27 |
|
Glucose 10%
Glucose
- Strength / route
- 10%; 500ml · Infusion
- Qty
- 4,000 Chai
- Total
- 35,600,000
- Group
- N4
- Manufacturer
- Fresenius Kabi Vietnam JSC (Vietnam)
- Province / Facility
- Ca Mau · 96145
|
893110402324 |
10%; 500ml
Infusion
|
Chai |
4,000
|
8,900
|
35,600,000
|
N4 |
Fresenius Kabi Vietnam JSC
Vietnam
|
Ca Mau
96145
|
2026-03-27 |
|
Glucose 30%
Glucose
- Strength / route
- 30% 500ml · Infusion
- Qty
- 650 Chai
- Total
- 10,010,000
- Group
- N4
- Manufacturer
- Fresenius Kabi Vietnam JSC (Vietnam)
- Province / Facility
- Ho Chi Minh City · 79431
|
VD-23167-15 |
30% 500ml
Infusion
|
Chai |
650
|
15,400
|
10,010,000
|
N4 |
Fresenius Kabi Vietnam JSC
Vietnam
|
Ho Chi Minh City
79431
|
2026-03-27 |
|
Glucovance 500mg/2,5mg
Glibenclamid + metformin
- Strength / route
- 2,5mg + 500mg · Oral
- Qty
- 10,000 Tablet
- Total
- 45,600,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Thai Nguyen · 19013
|
VN-20022-16 |
2,5mg + 500mg
Oral
|
Tablet |
10,000
|
4,560
|
45,600,000
|
N1 |
Merck Sante s.a.s
France
|
Thai Nguyen
19013
|
2026-03-27 |
|
Glucovance 500mg/2,5mg
Metformin + glibenclamid
- Strength / route
- 500mg/2,5mg · Oral
- Qty
- 10,000 Tablet
- Total
- 45,600,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Hanoi · 01055
|
VN-20022-16 |
500mg/2,5mg
Oral
|
Tablet |
10,000
|
4,560
|
45,600,000
|
N1 |
Merck Sante s.a.s
France
|
Hanoi
01055
|
2026-03-27 |
|
Glucovance 500mg/5mg
Metformin + glibenclamid
- Strength / route
- 500mg/5mg · Oral
- Qty
- 16,000 Tablet
- Total
- 75,408,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Hanoi · 01055
|
VN-20023-16 |
500mg/5mg
Oral
|
Tablet |
16,000
|
4,713
|
75,408,000
|
N1 |
Merck Sante s.a.s
France
|
Hanoi
01055
|
2026-03-27 |
|
Glumeron 60 MR
Gliclazid
- Strength / route
- 60mg · Oral
- Qty
- 60,000 Tablet
- Total
- 65,400,000
- Group
- N2
- Manufacturer
- DHG Pharmaceutical JSC – DHG Pharmaceutical Factory Branch in Hau Giang (Vietnam)
- Province / Facility
- Hanoi · 01107
|
VD-35985-22 |
60mg
Oral
|
Tablet |
60,000
|
1,090
|
65,400,000
|
N2 |
DHG Pharmaceutical JSC – DHG Pharmaceutical Factory Branch in Hau Giang
Vietnam
|
Hanoi
01107
|
2026-03-27 |
|
Glumeron 60 MR
Gliclazid
- Strength / route
- 60mg · Oral
- Qty
- 60,000 Tablet
- Total
- 65,400,000
- Group
- N2
- Manufacturer
- DHG Pharmaceutical JSC – DHG Pharmaceutical Factory Branch in Hau Giang (Vietnam)
- Province / Facility
- Hanoi · 01OR2
|
VD-35985-22 |
60mg
Oral
|
Tablet |
60,000
|
1,090
|
65,400,000
|
N2 |
DHG Pharmaceutical JSC – DHG Pharmaceutical Factory Branch in Hau Giang
Vietnam
|
Hanoi
01OR2
|
2026-03-27 |
|
Glumeron 60 MR
Gliclazid
- Strength / route
- 60mg · Oral
- Qty
- 60,000 Tablet
- Total
- 65,400,000
- Group
- N2
- Manufacturer
- DHG Pharmaceutical JSC – DHG Pharmaceutical Factory Branch in Hau Giang (Vietnam)
- Province / Facility
- Hanoi · 01E53
|
VD-35985-22 |
60mg
Oral
|
Tablet |
60,000
|
1,090
|
65,400,000
|
N2 |
DHG Pharmaceutical JSC – DHG Pharmaceutical Factory Branch in Hau Giang
Vietnam
|
Hanoi
01E53
|
2026-03-27 |
|
Glumeron 60 MR
Gliclazid
- Strength / route
- 60mg · Oral
- Qty
- 60,000 Tablet
- Total
- 65,400,000
- Group
- N2
- Manufacturer
- DHG Pharmaceutical JSC – DHG Pharmaceutical Factory Branch in Hau Giang (Vietnam)
- Province / Facility
- Hanoi · 01E64
|
VD-35985-22 |
60mg
Oral
|
Tablet |
60,000
|
1,090
|
65,400,000
|
N2 |
DHG Pharmaceutical JSC – DHG Pharmaceutical Factory Branch in Hau Giang
Vietnam
|
Hanoi
01E64
|
2026-03-27 |
